Heart attack recovery: can an Iron-Removing drug help?
NCT ID NCT05604131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug deferiprone can safely reduce harmful iron buildup in the heart after a severe heart attack. About 89 adults with a specific type of heart attack will receive either deferiprone or a placebo for 6 months. The goal is to see if lowering iron levels improves heart function and reduces complications like heart failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IU Methodist Hospital (IUHealth)
RECRUITINGIndianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.